Where is Abzena Holdings Investing $213 Million?

Abzena Holdings is investing $213 million soon toward a new biopharmaceutical location in Right to Work Sanford, North Carolina. This is good news because they also plan to create 325 new jobs. So this will be a great addition to the area’s economy!

From Area Development Magazine:

“We are very appreciative for the entire team representing North Carolina for their partnership and the office of U.S. Senator Thom Tillis during the decision process. […] We are delighted to support our customers and the patients they serve with this investment in North Carolina. This builds on the successful launch of our second cGMP biologics facility in San Diego in 2020.” […]

“Abzena recognized North Carolina as a leader in biotechnology and knew this was the right place to develop and manufacture new medicines and grow their business.” […]

“Innovative companies set a high bar for excellence, and with today’s decision, North Carolina once again meets and exceeds those standards. […] We welcome Abzena to the state’s growing life science industry cluster. As a former executive in this industry myself, it’s great to see how North Carolina is leading the way in the product lifecycle for new medicines that will improve and save lives.”


To read more updates on Right to Work states, click here.